Author | Year | A | B | C | D | E | F | G | H | I | J | K | L | Total |
---|
Luethi et al. | 2019 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 2 | 12 |
Luethi et al. | 2018 | 2 | 2 | 0 | 2 | 0 | 1 | 2 | 0 | 2 | 0 | 1 | 2 | 14 |
Di Muzio et al. | 2016 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 2 | 12 |
Kar et al. | 2016 | 2 | 2 | 0 | 2 | 0 | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 15 |
- Numbers A-H in heading signified: A,clearly stated study objectives; B,Inclusion of consecutive patientss; C, Prospective collection of data; D, Endpoints appropriate to the aim of the study; E, Unbiased assessment of the study endpoint; F, Follow-up period appropriate to the aim of the study; G, Loss to follow up less than 5%, H, Prospective calculation of the study size; I, A control group having the gold standard intervention; J, Contemporary groups; K, Baseline equivalence of groups; L, Statistical analyses adapted to the study design